Merck’s ENFLONSIA Receives Positive CHMP Opinion in Europe for Expanded RSV Prevention in High-Risk Children Up to 24 Months Merck & Co, known as MSD outside the United States and…
Novo Nordisk Submits FDA and EMA Applications for Etavopivat as Potential Disease-Modifying Treatment for Sickle Cell Disease Novo Nordisk today announced the submission of a New Drug Application (NDA) to…
Eli Lilly Breaks Ground on $3.5 Billion Lehigh Valley Manufacturing Facility to Expand Production of Next-Generation Obesity Medicines Eli Lilly and Company has officially broken ground on a new $3.5…
HeartBeam Reports Third Quarter 2026 Financial Results, Advances Heart Attack Assessment Strategy and Prepares for Pivotal U.S. Study HeartBeam, a medical technology company focused on transforming cardiac care through personalized…
Rocket Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress Across Its Cardiovascular Gene Therapy Pipeline Rocket Pharmaceuticals, Inc., a fully integrated, commercial-stage biotechnology company focused on developing genetic…
Biomatter Raises $18 Million in Oversubscribed Series A to Expand AI-Powered Enzyme Design and Accelerate Industrial Applications Biomatter, a biotechnology company specializing in custom enzyme design, has announced the successful…
PepGen Announces Pricing of $125 Million Public Offering to Advance Clinical Development of Oligonucleotide Therapies PepGen, a clinical-stage biotechnology company developing innovative oligonucleotide-based medicines for rare genetic diseases, has announced…
FDA Approves Promega OncoMate MSI Dx Analysis System as Companion Diagnostic for Merck’s KEYTRUDA in MSI-H Solid Tumors Promega Corporation has announced that the U.S. Food and Drug Administration (FDA)…
Alpha Cognition Reports Record Third-Quarter 2026 ZUNVEYL Revenue and Expanding Prescriber Adoption, Reaffirms Path to Profitability in 2027 Alpha Cognition Inc., a biopharmaceutical company focused on developing and commercializing novel…
enGene Therapeutics Appoints Erik Goluboff as Chief Medical Officer and Jason Duncan as Chief Legal and Administrative Officer enGene Therapeutics Inc., a clinical-stage biotechnology company focused on developing non-viral genetic…
Delcath Systems to Be Featured on Health Uncensored with Dr. Drew in Segment on Precision Oncology for Metastatic Liver Cancer Delcath Systems, Inc., an interventional oncology company focused on developing…
Teiko Publishes Bioanalysis Review Highlighting Sample Stabilization and Mass Cytometry for Immune Monitoring in Global Oncology Trials Teiko, a CLIA-certified clinical laboratory specializing in immune response monitoring, has announced the…